CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
26.96
+0.38 (1.43%)
Nov 2, 2026, 4:00 PM EST - Market closed
CeriBell Revenue
CeriBell had revenue of $28.10M in the quarter ending June 30, 2026, with 32.54% growth. This brings the company's total for the last twelve months to $101.96M, up 31.70% year-over-year. In the year 2025, CeriBell had annual revenue of $89.06M with 36.09% growth. That makes CeriBell the 22,528th largest company in the world by revenue and 3,279th in the United States.
Revenue (ttm)
$101.96M
Revenue Growth
+31.70%
P/S Ratio
10.15
Revenue / Employee
$311,817
Employees
327
Market Cap
1.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 89.06M | 23.62M | 36.09% |
| Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
| Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
| Dec 31, 2022 | 25.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
CBLL News
- 18 hours ago - Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution - GlobeNewsWire
- 5 days ago - Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - GlobeNewsWire
- 13 days ago - Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026 - GlobeNewsWire
- 4 weeks ago - Ceribell price target raised to $33 from $29 at TD Cowen - TheFly
- 4 weeks ago - Ceribell receives FDA 510k clearance of quantitative EEG trending, analysis - TheFly
- 4 weeks ago - Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis - GlobeNewsWire
- 7 weeks ago - Ceribell management to meet with BTIG - TheFly
- 2 months ago - Ceribell price target raised to $30 from $28 at BTIG - TheFly